DA32 Life Science Tech Acquisition Corp. (DALS) Stock Analysis

What DA32 Life Science Tech Acquisition Corp. does

Currently, DA32 Life Science Tech Acquisition Corp. does not engage in substantial operational activities. Its core objective is to finalize a business combination, which may involve a merger, an exchange of capital stock, an acquisition of assets or stock, or a corporate reorganization with other companies. The firm intends to pinpoint promising candidates for these combinations within the biotechnology and life science infrastructure sectors. Established in 2021, the company is based in New York, New York.

Key metrics

ETFs linked to DALS

Broad-market and Financial Services sector ETFs an investor holding DA32 Life Science Tech Acquisition Corp. is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how DALS fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Frequently asked questions

What is the ticker symbol for DA32 Life Science Tech Acquisition Corp.?

DA32 Life Science Tech Acquisition Corp. trades under the ticker DALS on NASDAQ.

Which exchange is DALS listed on?

DALS is listed on NASDAQ.

What sector does DA32 Life Science Tech Acquisition Corp. operate in?

DA32 Life Science Tech Acquisition Corp. is classified in the Financial Services sector (Shell Companies industry).

How can PortView help analyze DALS in a portfolio?

PortView shows DALS's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.